Consolidated Portfolio Review Corp Sells 606 Shares of The Procter & Gamble Company (NYSE:PG)

Consolidated Portfolio Review Corp cut its holdings in shares of The Procter & Gamble Company (NYSE:PG) by 4.9% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 11,811 shares of the company’s stock after selling 606 shares during the quarter. Consolidated Portfolio Review Corp’s holdings in Procter & Gamble were worth $2,046,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in the business. OneAscent Wealth Management LLC boosted its holdings in shares of Procter & Gamble by 24.6% during the 1st quarter. OneAscent Wealth Management LLC now owns 2,240 shares of the company’s stock valued at $363,000 after purchasing an additional 442 shares during the last quarter. Norris Perne & French LLP MI increased its stake in Procter & Gamble by 26.3% in the 1st quarter. Norris Perne & French LLP MI now owns 3,145 shares of the company’s stock worth $510,000 after acquiring an additional 655 shares during the last quarter. Independence Bank of Kentucky raised its holdings in shares of Procter & Gamble by 7.8% during the 1st quarter. Independence Bank of Kentucky now owns 29,187 shares of the company’s stock worth $4,736,000 after acquiring an additional 2,110 shares in the last quarter. Occidental Asset Management LLC boosted its position in shares of Procter & Gamble by 14.6% during the 1st quarter. Occidental Asset Management LLC now owns 2,500 shares of the company’s stock valued at $406,000 after acquiring an additional 318 shares during the last quarter. Finally, Hodges Capital Management Inc. increased its position in Procter & Gamble by 14.7% in the first quarter. Hodges Capital Management Inc. now owns 9,912 shares of the company’s stock worth $1,608,000 after purchasing an additional 1,273 shares during the last quarter. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Procter & Gamble

In other Procter & Gamble news, insider Balaji Purushothaman sold 12,800 shares of Procter & Gamble stock in a transaction on Thursday, October 24th. The shares were sold at an average price of $168.99, for a total value of $2,163,072.00. Following the transaction, the insider now directly owns 11,566 shares of the company’s stock, valued at approximately $1,954,538.34. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Procter & Gamble news, insider Balaji Purushothaman sold 12,800 shares of the firm’s stock in a transaction dated Thursday, October 24th. The stock was sold at an average price of $168.99, for a total value of $2,163,072.00. Following the completion of the sale, the insider now owns 11,566 shares of the company’s stock, valued at approximately $1,954,538.34. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Susan Street Whaley sold 634 shares of the company’s stock in a transaction dated Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total transaction of $108,826.10. Following the transaction, the insider now owns 19,341 shares in the company, valued at approximately $3,319,882.65. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 397,986 shares of company stock valued at $67,642,430 over the last 90 days. Insiders own 0.18% of the company’s stock.

Procter & Gamble Stock Down 0.8 %

Shares of NYSE:PG opened at $168.22 on Friday. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50. The business’s 50 day moving average is $171.93 and its 200 day moving average is $167.62. The stock has a market cap of $396.16 billion, a P/E ratio of 29.00, a price-to-earnings-growth ratio of 3.67 and a beta of 0.41. The Procter & Gamble Company has a 52-week low of $142.50 and a 52-week high of $177.94.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.90 by $0.03. The business had revenue of $21.74 billion during the quarter, compared to analyst estimates of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The company’s quarterly revenue was down .6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.83 EPS. Sell-side analysts predict that The Procter & Gamble Company will post 6.94 EPS for the current year.

Procter & Gamble Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be given a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a dividend yield of 2.39%. The ex-dividend date of this dividend is Friday, October 18th. Procter & Gamble’s payout ratio is 69.48%.

Analysts Set New Price Targets

Several research firms have commented on PG. DA Davidson increased their price objective on shares of Procter & Gamble from $159.00 to $160.00 and gave the company a “neutral” rating in a research report on Monday, October 21st. TD Cowen assumed coverage on Procter & Gamble in a research report on Tuesday, July 23rd. They issued a “buy” rating and a $189.00 price target for the company. Evercore ISI upped their price objective on Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a research report on Monday, October 21st. Citigroup lifted their target price on Procter & Gamble from $177.00 to $190.00 and gave the stock a “buy” rating in a report on Wednesday, July 10th. Finally, Piper Sandler began coverage on Procter & Gamble in a research report on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price target for the company. Nine equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $177.00.

Procter & Gamble Company Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.